Skip To Content

    DNA-Based Diabetes Vaccine Could Potentially Aid Millions

    Researchers are conducting trials of a vaccine that could help millions of people suffering from Type 1 diabetes, the most severe form. The so-called "reverse" vaccine works in the opposite way of most -- instead of boosting immune responses, it shuts down part of the system that destroys insulin-creating pancreatic cells. Future trials could lead to widespread use, though it'll probably take years.

    Follow NowThis News on Facebook and Twitter.

    The NowThis News app is live -- and it's FREE! Download it.